Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Prevention of Acute Ischemic Events - 2 (APPRAISE-2)
2008-008298-77Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute coronary syndrome (ACS), myocardial infarction (MI) and ischemic stroke comparing Apixaban arm with Placebo arm (2 arms). Started Mar 2009; status: completed.
02
Drugs
apixaban
03
Conditions
acute coronary syndrome (ACS)myocardial infarction (MI)ischemic stroke
Beyond the preview
Go deeper on 2008-008298-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008298-77.